This is a routine CFO transition to a fractional arrangement with no financial red flags. Monitor the next 10-Q for any changes in financial reporting quality or audit outcomes, but no immediate trading catalyst.
Price Chart
Executive Summary
Mira Pharmaceuticals disclosed the departure of CFO Alan Weichselbaum (effective June 6, 2026) and the appointment of Andriy Mushak as fractional CFO via a consulting agreement with LMAM Consulting Group, LLC. The departure was not due to any disagreement with the company. Mr. Mushak will be paid $6,000 per month for his services. This is a routine CFO transition to a fractional arrangement for a small-cap pharmaceutical company.
Key Facts
- Alan Weichselbaum ceased serving as CFO effective June 6, 2026; departure not due to any disagreement with the company.
- Andriy Mushak appointed as fractional CFO effective June 6, 2026.
- Mr. Mushak is a CPA with over 20 years of experience and will provide services through LMAM Consulting Group, LLC.
- Compensation is $6,000 per month under a one-year consulting agreement.
- No family relationships or material interests in transactions requiring disclosure.
Financial Impact
CFO compensation of $6,000 per month ($72,000 annually) — immaterial relative to the company's $42M market cap.
Risk Factors
- Fractional CFO may have limited availability compared to a full-time CFO, potentially impacting financial reporting cadence.
- No material financial data or guidance was provided in this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-027751 |
| Document: form8-k.htm | 0001493152-26-027751 |
| Document: 0001493152-26-027751-index-headers.html | 0001493152-26-027751 |
| Document: 0001493152-26-027751-index.html | 0001493152-26-027751 |
| Document: 0001493152-26-027751.txt | 0001493152-26-027751 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $0.6290 $0.6195 | ▼ −1.51% | ▼ −0.99% | $0.5328 (−15.29%) |
Oct 22, 2026 4d ago | Press Release | $0.6289 $0.6195 | ▼ −1.49% | ▼ −0.97% | $0.5328 (−15.28%) |
Sep 17, 2026 5w ago | 8-K | $0.7593 $0.8323 | ▲ +9.61% | ▲ +9.73% | $0.5328 (−29.83%) |
Sep 17, 2026 5w ago | Press Release | $0.7593 $0.8323 | ▲ +9.61% | ▲ +9.73% | $0.5328 (−29.83%) |
Sep 1, 2026 7w ago | 8-K | $0.8600 $0.8495 | ▼ −1.22% | ▼ −1.66% | $0.5328 (−38.05%) |
Aug 6, 2026 11w ago | 8-K | $0.6782 $0.7400 | ▲ +9.11% | ▲ +8.50% | $0.5328 (−21.44%) |
Jul 10, 2026 15w ago | 8-K | $0.9245 $0.9097 | ▼ −1.60% | ▼ −0.84% | $0.5328 (−42.37%) |
Jul 6, 2026 16w ago | 8-K | $0.9549 $0.9478 | ▼ −0.74% | ▼ −0.27% | $0.5328 (−44.20%) |
Jun 17, 2026 18w ago | 8-K | $0.9782 $0.9524 | ▼ −2.64% | ▼ −3.42% | $0.5328 (−45.53%) |
Jun 8, 2026 19w ago | 8-K | $0.9767 $0.9802 | ▲ +0.36% | ▲ +1.93% | $0.5328 (−45.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers